Dr. Marlene Fonseca is the Phase I Clinical Director, specializing in Cardiology and Clinical Pharmacology. Her dual board certification and Advanced Life Support (ALS) certification provide exceptional safety oversight for early-phase trials. As a Principal Investigator, she has led over 50 Phase I trials among 150+ trials total. Her expertise encompasses all trial types – from generics and innovative drugs (First-in-Human, SAD, MAD) to those with stringent safety profiles and specialized cardiac assessments like Thorough QT (TQT) studies.
